• 1. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 4. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 5. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625

3-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine: A Comprehensive Overview

3-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine is a heterocyclic compound with the CAS number 740061-36-3, which has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the class of pyrazolopyridine derivatives, a structurally diverse group known for their broad spectrum of biological activities. The unique arrangement of nitrogen atoms in its ring system imparts distinct pharmacological properties, making it a valuable scaffold for drug discovery and development.

The chemical structure of 3-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine features a fused ring system consisting of a pyrazole ring linked to a pyridine ring. The presence of a methyl group at the 3-position and the tetrahydropyrazolopyridine core contribute to its complex electronic and steric properties. These features are crucial in determining its interaction with biological targets, such as enzymes and receptors, which underpin its potential therapeutic applications.

Recent advancements in computational chemistry and molecular modeling have enabled researchers to delve deeper into the mechanistic aspects of this compound. Studies have shown that the binding affinity of 3-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine towards various biological targets can be modulated by subtle changes in its chemical environment. This has opened up new avenues for designing analogs with enhanced pharmacological profiles.

In the realm of neuropharmacology, 3-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine has been investigated for its potential role in modulating neurotransmitter systems. Preliminary studies suggest that it may interact with serotonin receptors, which are implicated in conditions such as depression and anxiety disorders. The compound's ability to modulate these receptors without causing significant side effects makes it an attractive candidate for further development.

Another area where this compound has shown promise is in anti-inflammatory research. Chronic inflammation is a hallmark of numerous diseases, including autoimmune disorders and cardiovascular conditions. By targeting inflammatory pathways at the molecular level, 3-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine may offer a novel therapeutic approach. Experimental data indicates that it can inhibit the production of pro-inflammatory cytokines by modulating key signaling cascades.

The synthesis of 3-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies have been employed to improve yield and purity. For instance, catalytic hydrogenation techniques have been utilized to construct the tetrahydropyrazolopyridine core efficiently. These synthetic advances are essential for scaling up production and conducting large-scale pharmacological studies.

The pharmacokinetic properties of 3-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine are also under investigation to ensure its clinical viability. Studies have focused on its absorption, distribution, metabolism, and excretion (ADME) profiles. Understanding these parameters is crucial for optimizing dosing regimens and minimizing potential toxicity. Advanced analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS) have been instrumental in characterizing its metabolic pathways.

In conclusion,3-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,c]pyridine (CAS no 740061-36-3) represents a promising lead compound in pharmaceutical research due to its unique structural features and diverse biological activities. Ongoing studies aim to elucidate its mechanism of action and explore new therapeutic applications across various disease areas. As our understanding of this compound grows,future research will likely uncover even more innovative uses for this versatile heterocyclic molecule.

• 1177343-19-9(3-Ethyl-4,5,6,7-tetrahydro-1H-pyrazolo4,3-cpyridine Dihydrochloride)
• 410544-19-3(4,5,6,7-tetrahydro-1H-pyrazolo4,3-cpyridine)
• 933716-16-6((4,5,6,7-tetrahydro-2H-pyrazolo4,3-cpyridin-3-yl)methanamine)
• 35005-71-1(5-Benzyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine)
• 1177345-48-0(3-Cyclopropyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine)
• 1187830-85-8(4,5,6,7-Tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride)
• 157327-46-3(3-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine dihydrochloride)
• 157327-44-1(1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine dihydrochloride)
• 635712-89-9(7,7-dimethyl-1,4,5,6-tetrahydropyrazolo[4,3-c]pyridine)
• 1177284-02-4(3-Isopropyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine)